» Articles » PMID: 9876207

Effect of the Growth Rate of Pseudomonas Aeruginosa Biofilms on the Susceptibility to Antimicrobial Agents: Beta-lactams and Fluoroquinolones

Overview
Journal Chemotherapy
Specialty Pharmacology
Date 1999 Jan 7
PMID 9876207
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The growth rate of biofilm bacteria of a leucine-requiring mutant Pseudomonas aeruginosa HU1 was regulated by the leucine concentration in a chemically-defined medium. The semiquantitative measurement of glycocalyx and scanning electron microscopy revealed that the kinetics of HU1-biofilm formation were dependent on the incubation time and the leucine concentration in the medium. The effect of the growth rate of biofilm cells on their susceptibility to antimicrobial agents, three beta-lactams and four fluoroquinolones, was evaluated. beta-Lactams showed weak bactericidal activity to biofilm cells; the activity was greater in younger biofilm cells growing in high concentrations of leucine. Fluoroquinolones revealed strong bactericidal activity to biofilm bacteria regardless of the growth rate. The following is suggested: the bactericidal action of beta-lactams against biofilm cells is affected by the cell growth rate, while that of fluoroquinolones is considerably greater and independent on the growth rate.

Citing Articles

Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study.

Hanssen J, van der Wal R, Mahdad R, Keizer S, Delfos N, van der Lugt J Antimicrob Agents Chemother. 2024; 68(12):e0123224.

PMID: 39535202 PMC: 11619448. DOI: 10.1128/aac.01232-24.


Antibiotics with antibiofilm activity - rifampicin and beyond.

Ferreira L, Pos E, Nogueira D, Ferreira F, Sousa R, Abreu M Front Microbiol. 2024; 15:1435720.

PMID: 39268543 PMC: 11391936. DOI: 10.3389/fmicb.2024.1435720.


Modern Microbiological Methods to Detect Biofilm Formation in Orthopedy and Suggestions for Antibiotic Therapy, with Particular Emphasis on Prosthetic Joint Infection (PJI).

Mikzinski P, Kraus K, Widelski J, Paluch E Microorganisms. 2024; 12(6).

PMID: 38930580 PMC: 11205407. DOI: 10.3390/microorganisms12061198.


Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics.

Nicholls P, Clark J, Gu Liu C, Terwilliger A, Maresso A Infect Immun. 2023; 91(8):e0006523.

PMID: 37404162 PMC: 10429645. DOI: 10.1128/iai.00065-23.


Antimicrobial treatment of patients with a periprosthetic joint infection: basic principles.

Rottier W, Seidelman J, Wouthuyzen-Bakker M Arthroplasty. 2023; 5(1):10.

PMID: 36864531 PMC: 9979546. DOI: 10.1186/s42836-023-00169-4.